“Inoculation with tumour cell membrane-derived vaccines is a promising strategy to activate B cells, yet their efficiency is limited due to lack of co-stimulatory molecules,” the researchers ...
It is conceivable that the treated B cells activate macrophages and natural killer cells of the immune system in this way. The research team will now clarify whether this assumption is correct in ...